MARKET

AVHHL

AVHHL

Avita Medical
OTCPK
1.420
NaN%
Opening 09:30 08/19 EDT
OPEN
--
PREV CLOSE
1.420
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
1.420
52 WEEK LOW
0.555
MARKET CAP
219.58M
P/E (TTM)
-0.9839
1D
5D
1M
3M
1Y
5Y
1D
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
Barchart · 1d ago
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
Barchart · 08/07 07:45
AVITA Medical to Announce Second Quarter 2026 Financial Results
Barchart · 07/14 15:05
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting
Barchart · 06/18 07:40
AVITA Medical to Host Investor Webinar Briefing
Barchart · 05/17 17:00
Avita reaffirms $80M-$85M 2026 revenue guidance as RECELL reimbursement normalizes and Cohealyx data targets faster graft readiness
Seeking Alpha · 05/14 23:31
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
Barchart · 04/15 08:20
AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting
Barchart · 04/14 06:45
More
About AVHHL
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company solutions are designed to optimize wound healing, accelerate patient recovery, and improve clinical and economic outcomes across the continuum of acute wound management. Its technologies address critical healing needs arising from burns, traumatic injuries, and surgical repairs, through a portfolio and complementary products that support wound bed preparation, definitive closure, and recovery. Its portfolio includes RECELL and two complementary wound care products, PermeaDerm and Cohealyx. Its RECELL technology platform is an autologous cell harvesting technology that enables clinicians to create a suspension of a patient's own skin cells, called Spray-On Skin, at the point of care. Its PermeaDerm is a biosynthetic wound matrix that manufactures, markets, and distributes in the United States, under multi-year agreements with Stedical.

Webull offers AVITA Medical Inc stock information, including OTCPK: AVHHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVHHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVHHL stock methods without spending real money on the virtual paper trading platform.